NCT06174922View on ClinicalTrials.gov

A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Allergic Bronchopulmonary Aspergillosis
Interventions
DRUG

Prednisolone

Prednisolone for 4 months

DRUG

Itraconazole

SUBA-itraconazole for 4 months

Trial Locations (1)

160012

RECRUITING

Chest Clinic, Dept. of Pulmonary Medicine, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER